GL1X · GenesisL1 explorer

MolNFT v1 · #103838 · protein

Crystal structure of apethermo-dbp-RP2

4PSN · Ssdna binding protein: “Crystal structure of apethermo-dbp-RP2”. X-ray diffraction, 20 pockets (best druggability 0.78). MolNFT v1 #103838 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
4PSN
Type
protein
Length
881 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Ssdna binding protein
UniProt
Q9YAS7
Pockets
20 · best druggability 0.78

Structure

x-ray diffraction · 3 distinct chains · 40% helix, 34% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASsdna binding proteinprotein22041% helix, 34% strandQ9YAS7
BSsdna binding proteinprotein21942% helix, 34% strandQ9YAS7
C, DSsdna binding proteinprotein22138% helix, 33% strandQ9YAS7

Ligands and binding sites

  • IMD · Imidazole · additive · 6 copies · chains A, D, B, C
  • GOL · Glycerol · additive · 2 copies · chains A, C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13230.780.8936empty
23520.780.8840GOL, IMD
35110.660.7775IMD
43470.580.7736IMD
53320.570.7638empty

Interfaces

6 interfaces between chains.

  • B–C · 2837 Ų buried · 30 hydrogen bonds · protein-protein
  • A–D · 2801 Ų buried · 37 hydrogen bonds · protein-protein
  • A–C · 903 Ų buried · 19 hydrogen bonds · protein-protein
  • C–D · 900 Ų buried · 15 hydrogen bonds · protein-protein
  • B–D · 886 Ų buried · 12 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 12 modified (engineered).

Compared structures

  • 4PSN · Crystal structure of apeThermo-DBP-RP2 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.